68001-390 : Mitomycin 20 mg/40ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 68001-390
Labeler: Bluepoint Laboratories
Product Type: Human Prescription Drug
Drug Name:  Mitomycin
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: ANDA064144
Rev. Date: 


NDC Package Codes:

  • 68001-390-77: 1 VIAL IN 1 BOX, UNIT‑DOSE (68001‑390‑77) > 40 ML IN 1 VIAL (68001‑390‑78)

Active Ingredients:

  • Mitomycin

Dosage Strength:

  • 20 mg/40mL

Pharmaceutical Classes:

  • Alkylating Activity [MoA]
  • Alkylating Drug [EPC]

Related Products:

Based on records with the same trade name.
  • 68001-389 Mitomycin 5 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
  • 68001-391 Mitomycin 40 mg/80ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
  • 0143-9135 Mitomycin 20 mg Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
  • 0143-9136 Mitomycin 40 mg Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
  • 0143-9279 Mitomycin 20 mg/40ml Intravenous Injection, Powder, Lyophilized, for Solution by West-ward Pharmaceuticals Corp
  • 0143-9280 Mitomycin 40 mg/80ml Intravenous Injection, Powder, Lyophilized, for Solution by West-ward Pharmaceuticals Corp
  • 16729-108 Mitomycin 20 mg/40ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc
  • 16729-115 Mitomycin 5 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc
  • 16729-116 Mitomycin 40 mg/80ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc
  • 16729-246 Mitomycin 5 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc
  • 16729-247 Mitomycin 20 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc
  • 16729-248 Mitomycin 40 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc
  • 25021-250 Mitomycin 5 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • 25021-251 Mitomycin 20 mg/40ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • 25021-252 Mitomycin 40 mg/80ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • 55150-450 Mitomycin 5 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Eugia Us LLC
  • 55150-451 Mitomycin 20 mg/40ml Intravenous Injection, Powder, Lyophilized, for Solution by Eugia Us LLC
  • 55150-452 Mitomycin 40 mg/80ml Intravenous Injection, Powder, Lyophilized, for Solution by Eugia Us LLC
  • 65219-564 Mitomycin 5 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
  • 65219-566 Mitomycin 20 mg/40ml Intravenous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 68001-390 QR Code

< Prev: 68001-389Next: 68001-391 >

Related Discussions:

bcg vs. mitomycin
treatment with mitomycin on bladder cancer was not tolerated. physician wishes to treat now with BCG. Comments?...
material safety data sheet-mitomycin
mitomycin ## Here's the site for that product with such information for you: Material Safety Data Mitomycin Click He... 2 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.